Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYCS | P99999 | 4/20 | 0.83 |
| ▸ | TOP1 | P11387 | 4/20 | 0.74 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | STAT1 | P42224 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14246889 | 1.00 | CYCS (0.83) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL30999674 | 0.94 | CYCS (0.80) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL26089781 | 0.93 | CYCS (0.78) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL12842182 | 0.92 | CYCS (0.97) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL25395706 | 0.88 | CYCS (0.67) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL30493187 | 0.86 | TOP1 (0.68) | CYCSTOP1ENPP2TERTSTAT3 | |
| SCHEMBL25395955 | 0.86 | TOP1 (0.68) | CYCSTOP1ENPP2TERTSTAT3 | |
| SCHEMBL25392157 | 0.86 | CYCS (0.83) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL709532 | 0.85 | TOP1 (1.00) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL29354037 | 0.85 | TOP1 (1.00) | CYCSTOP1ENPP2ABCG2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117482993-A | Method for preparing hydrogen peroxide based on amorphous porphyrin supermolecule photocatalyst | 江南大学 | 2024-02-02 | — | — | CN | claimed |
| WO-2022114481-A1 | SKIN DISEASE TREATMENT DEVICE AND SKIN DISEASE TREATMENT SYSTEM COMPRISING SAME | 주식회사 비아이바이오포토닉스 | 2022-06-02 | — | — | WO | claimed |
| US-12546743-B2 | Electrochemical sensor and related methods | UNIVERSITY OF SOUTH FLORIDA (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3206987-B2 | NANOPARTICLES FOR PHOTODYNAMIC THERAPY, X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF | UNIV CHICAGO (US) | 2024-07-24 | — | — | EP | disclosed |
| CN-117482993-A | Method for preparing hydrogen peroxide based on amorphous porphyrin supermolecule photocatalyst | 江南大学 | 2024-02-02 | — | — | CN | disclosed |
| US-20230296554-A1 | ELECTROCHEMICAL SENSOR AND RELATED METHODS | UNIVERSITY OF SOUTH FLORIDA | 2023-09-21 | — | — | US | disclosed |
| WO-2022114481-A1 | SKIN DISEASE TREATMENT DEVICE AND SKIN DISEASE TREATMENT SYSTEM COMPRISING SAME | 주식회사 비아이바이오포토닉스 | 2022-06-02 | — | — | WO | disclosed |
| WO-2022102943-A1 | LIGHT-BASED WATER TREATMENT DEVICE AND WATER QUALITY MANAGEMENT SYSTEM INCLUDING SAME | 주식회사 비아이바이오포토닉스 | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12546743-B2 | Electrochemical sensor and related methods | EPX, MUC1, EPCAM | CYCS 2095/4885TOP1 4862/4885ENPP2 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.